AKT1 and neoplasm: Similarly, scRNA-Seq data from TNBC patients (NCT03197389)34 indicated that tumor cells with high FAM114A1 expression presented increased PI3K/AKT activation and reduced tumor antigen presentation (Fig. 2b).